Trademark Overview
On Monday, October 14, 2024, a trademark application was filed for EUREKA INTERNATIONAL GROUP with the United States Patent and Trademark Office. The USPTO has given the EUREKA INTERNATIONAL GROUP trademark a serial number of 98800329. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, October 14, 2024. This trademark is owned by Eureka Biotech Inc.. The EUREKA INTERNATIONAL GROUP trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:
freight logistics management; freight forwarding; freight brokerage; freight transportation brokerage; cargo handling; cargo transportation; warehouse storage; rental of warehouse space; warehousing services; warehousing information
real estate development; real estate sales management; real estate brokerage services; insurance brokerage services; financial services, namely, real estate brokerage services and mortgage brokerage services; real estate services, namely, rental property management; real estate consultation; consultation in the field of finance; Financial consulting services, namely, expert analysis in finance; fund investment consultation; venture capital fund management; head fund management; financial services; investment advice; funds investments; investment consultation; investment management; investment brokerage
business consultation services; business consulting and business information for enterprises; business consulting and information services; business consulting in the consumer products industry; business consulting services for digital transformation; business marketing services; digital marketing services; business marketing consultation services; advertising services; digital advertising services; business management and consultation services in the field of real estate and insurance
scientific research in the field of organoid technology; drug screening for scientific research purposes; stem cell research services